Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006460 |
YEM_ID: | YEM-279 |
ID: | TCMBANKHE006460/YEM-279 |
植物拉丁名: |
|
功能与主治: | To regulate center and increase appetite, boost lung and quiet heart, disinhibit urine./Inappetence, inhibited urination, edema, urethral stone. |
药用植物名: | 玉蜀黍 |
药名: | 玉蜀黍 |
来源: | 云南民族药物志：第二卷 |
药用部位: | seed |
使用民族: | 白族/傣族/佤族/彝族/藏族 |
TCM_ID_id: | 3197 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN003075 | zederone | CHEBI:80915; 7727-79-9; AKOS032948437; C17085; Zederone | C15H18O3 | 246.3 g/mol | CC1=CCCC2(C(O2)C(=O)C3=C(C1)OC=C3C)C |
| TCMBANKIN005177 | pyrimidinone | (5-methyl-2-propan-2-yl-cyclohexyl) 5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-1,3-oxathiolane-2-carboxylate; DA-16835; I06-0807; 147027-10-9; [(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl] (2R,5S)-5-(4-amino-2-oxopyrimidin-1-yl)-1,3-oxathiolan; [1R-[1-A(2S*,5R*),2beta,5beta]]-5-(4-Amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic acid 5-methyl-2-(1-methylethyl)cyclohexyl ester; 2-ISOPROPYL-5-METHYLCYCLOHEXYL 5-(4-AMINO-2-OXOPYRIMIDIN-1-YL)-1,3-OXATHIOLANE-2-CARBOXYLATE; CARBOXYMENTHOLYL)-1,3-; 2-isopropyl-5-methylcyclohexyl 5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate; 5-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic acid 5-methyl-2-(1-methylethyl)cyclohexyl ester; C18H27N3O4S; S025; A808589; SCHEMBL2320654; BG01669627; (1R,2S,5R)-menthyl-5R-hydroxy-[1,3-oxathiolane-2R-; VC30624; OXATHIOLAN-5-YL]-2-(1H)-; SC-16316; FT-0652021; QMYKWNYBSBURDT-UHFFFAOYSA-N; AKOS015895305; J-500328; KB-195824; 5-(4-amino-2-oxo-1-pyrimidinyl)-1,3-oxathiolane-2-carboxylic acid (5-methyl-2-propan-2-ylcyclohexyl) ester; AC-18951; 1,3-Oxathiolane-2-carboxylicacid, 5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-,5-methyl-2-(1-methylethyl)cyclohexyl ester, [1R-[1a(2S*,5R*),2b,5b]]- (9CI); 147126-73-6; (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]oxathiolane-2-carboxylic acid; ACMC-1C1HG; CA0097; FT-0658688; (2R-Cis)-4-AMINO-1-[2(2-; I06-0808; 126A736; CTK4C5269 | C4H4N2O | 96.09 g/mol | C1=CNC(=O)N=C1 |
| TCMBANKIN014003 | zeta-carotene | LS-187070; xi-Carotene; CHEBI:28068; AC1NQXL2; BIWLELKAFXRPDE-WTXAYMOSSA-N; 2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,26,30-undecaene; C05430; (6E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,26,30-undecaene; all-trans-zeta-carotene; zeta-Carotene; Zeta-Carotin; 7,8,7',8'-tetrahydro-psi,psi-carotene; LS-187678; LMPR01070256; 13587-06-9; CHEBI:27362 | C40H60 | 540.9 g/mol | CC(=CCCC(=CCCC(=CC=CC(=CC=CC=C(C)C=CC=C(C)CCC=C(C)CCC=C(C)C)C)C)C)C |
| TCMBANKIN031326 | 1-(2-hydroxyphenylamino)-1-deoxy-β-gentio-bioside 1,2-carbamate | C19H25NO12 | C1=CC=C(C(=C1)N2C3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)OC2=O)O | ||
| TCMBANKIN032500 | alloimperatorine | CC(=CCC1=C2C(=C(C3=C1OC(=O)C=C3)O)C=CO2)C | |||
| TCMBANKIN041579 | chrysoeriol 6-c-β-boivinopyranosyl-7-o-β-glucopyranoside | C28H32O14 | CC1C(C(CC(O1)C2=C(C=C3C(=C2O)C(=O)C=C(O3)C4=CC(=C(C=C4)OC)O)OC5C(C(C(C(O5)CO)O)O)O)O)O | ||
| TCMBANKIN049715 | Chrysoeriol 6-C-β-L-boivinopyranoside | ||||
| TCMBANKIN058058 | galacturonic acid | d-galacturonic acid;d-galacturonicacid | C6H10O7 | 194.14 g/mol | C1(C(C(OC(C1O)O)C(=O)O)O)O |
| TCMBANKIN058377 | tryptamine | tryptamine sulfate;TSS;KBioSS_000393; 2-(1H-indol-3-yl)ethylamine; DivK1c_000862; SMR000112268; IDI1_000862; 2-(3-Indolyl)ethylamine; 2-Indol-3-ylethylamine; KBio3_002903; SDCCGMLS-0066798.P001; 2-(1H-INDOL-3-YL)ETHANAMINE; KBio1_000862; Indol-3-ethylamine; NCGC00095081-01; KBioGR_001459; BSPBio_003400; Spectrum_000033; Indole, 3-(2-aminoethyl)-; SPECTRUM1503922; 193747_ALDRICH; 1H-Indole-3-ethanamine; Lopac-246557; SPBio_000945; AIDS072303; 5-22-10-00045 (Beilstein Handbook Reference); AIDS-072303; CHEBI:16765; EINECS 200-510-5; Spectrum2_000873; Lopac0_000061; MT4; TRYPTAMINE; Spectrum3_001890; AE-848/30735051; Spectrum4_000850; NINDS_000862; (Amino-2 ethyl)-3 indole [French]; NCGC00095081-04; C00398; BRN 0125513; KBio2_000393; 2-(Indol-3-yl)ethylamine; 3-(2-aminoethyl)indole; MLS000515794; TSH; NCGC00014994-01; NCGC00095081-02; KBio2_005529; Oprea1_870097; Spectrum5_001296; KBio2_002961; SBB003963; 61-54-1 | C10H12N2 | 160.22 g/mol | C1=CC=C2C(=C1)C(=CN2)CCN |
| TCMBANKIN058390 | tryptanthrine | AC1L2K2A; SMR000386951; Indolo(2,1-b)quinazoline-6,12-dione; NSC-349447; MLS001049121; SR-01000521538-1; Indolo(2,1-b)quinazoline-6,12-dione (8CI)(9CI); FT-0733127; Couroupitine a; Tryptanthrin; KS-00000C3R; C-45803; Tryptantherin; NCGC00160337-02; GNF-PF-2691; NSC349447; AK-57813; TCMDC-125859; Tryptanthrin, >=98% (HPLC); NCI60_003113; ZB000930; DS-15687; KB-254423; SR-01000521538-4; ST047334; CHEMBL306946; CJ-00188; Indolo[2,1-b]quinazoline-6,12-dione; 5941AA; NCGC00160337-01!TRYPTANTHRINE; 13220-57-0; SCHEMBL2426211; STK078931; NCGC00160337-01; AKOS000671350; Bio-0284; HMS2271H05; Indolo[2,1-b]quizoline-6,12-dione; SY017117; 11-hydrobenzo[d]quinazolino[3,2-a]azolidine-6,12-dione; ANW-68868; ZINC33299; MCULE-7521697515; CTK0H6551; TRA0036916; SR-01000521538; J-006143; AX8156048; BDBM50240612; AC1Q1HJD; TC-157613; K-4146; Tryptanthrine; D0I9AT; MFCD00012073; GTPL8224; CCG-208326; NSC 349447; AJ-08570; CHEBI:9768; DTXSID90157431; VQQVWGVXDIPORV-UHFFFAOYSA-N; C10742; Oprea1_754264; Indolo[2,12-dione; MolPort-002-516-459; AC1L2K2A; indolo[2,1-b]quinazoline-6,12-quinone; SMR000386951; Indolo(2,1-b)quinazoline-6,12-dione; NSC-349447; MLS001049121; SR-01000521538-1; Indolo(2,1-b)quinazoline-6,12-dione (8CI)(9CI); FT-0733127; Couroupitine a; Tryptanthrin; KS-00000C3R; C-45803; Tryptantherin; NCGC00160337-02; GNF-PF-2691; NSC349447; AK-57813; TCMDC-125859; Tryptanthrin, >=98% (HPLC); NCI60_003113; ZB000930; DS-15687; KB-254423; SR-01000521538-4; ST047334; CHEMBL306946; CJ-00188; tryptanthrin ; Indolo[2,1-b]quinazoline-6,12-dione; 5941AA; NCGC00160337-01!TRYPTANTHRINE; 13220-57-0; SCHEMBL2426211; STK078931; NCGC00160337-01; AKOS000671350; Bio-0284; indolo[2,1- b]quinazoline alkaloid; HMS2271H05; indolo-[2,1-b]-quinazoline-6,12-dione; Indolo[2,1-b]quizoline-6,12-dione; SY017117; 11-hydrobenzo[d]quinazolino[3,2-a]azolidine-6,12-dione; ANW-68868; ZINC33299; MCULE-7521697515; CTK0H6551; TRA0036916; AIDS017287; SR-01000521538; J-006143; ZINC00033299; AX8156048; BDBM50240612; 6,12-dihydro-6, 12-dioxoindolo-(2,1-b)-quinazoline; AC1Q1HJD; TC-157613; K-4146; Tryptanthrine; D0I9AT; MFCD00012073; GTPL8224; CCG-208326; NSC 349447; AJ-08570; AIDS-017287; CHEBI:9768; DTXSID90157431; VQQVWGVXDIPORV-UHFFFAOYSA-N; C10742; Oprea1_754264; Indolo[2,12-dione; MolPort-002-516-459; tryptanthrin | C15H8N2O2 | 248.24 g/mol | C1=CC=C2C(=C1)C(=O)N3C4=CC=CC=C4C(=O)C3=N2 |
| TCMBANKIN058810 | alloimperatorin | 9-Hydroxy-4-(3-methyl-2-butenyl)-7H-furo(3,2-g)(1)benzopyran-7-one; NSC 301051; DTXSID20214400; AC1Q6A0B; CHEBI:2599; 9-hydroxy-4-(3-methylbut-2-enyl)furo[3,2-g]chromen-7-one; KDXVVZMYSLWJMA-UHFFFAOYSA-N; ZINC898013; 9-Hydroxy-4-(3-methyl-2-butenyl)-7H-furo[3,2-g]chromen-7-one; 7H-Furo[3,2-g][1]benzopyran-7-one; 9-hydroxy-4-(3-methyl-2-butenyl)-; 642-05-7; UNII-3043NX3603; MCULE-9129731017; 9085AF; ST4140654; Alloimperatorin; 9-hydroxy-4-(3-methylbut-2-en-1-yl)-7H-furo[3,2-g]chromen-7-one; 5-Benzofuranacrylic acid, 6,7-dihydroxy-4-(3-methyl-2-butenyl)-, .delta.-lactone; allo-imperatorin; Prangenidin; 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-hydroxy-4-(3-methyl-2-butenyl)-; STK691969; AKOS000276831; 3043NX3603; BG00977034; SCHEMBL6272567; MolPort-000-880-983; AC1L2C0Q; 7H-Furo[3, 9-hydroxy-4-(3-methyl-2-butenyl)-; C09053; NSC301051; NSC-301051; alloimperalorin; | C16H14O4 | 270.28 g/mol | CC(=CCC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)O)C |
| TCMBANKIN058833 | zeta-carotene | LS-187070; xi-Carotene; CHEBI:28068; AC1NQXL2; BIWLELKAFXRPDE-WTXAYMOSSA-N; 2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,26,30-undecaene; C05430; (6E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,26,30-undecaene; all-trans-zeta-carotene; zeta-Carotene; Zeta-Carotin; 7,8,7',8'-tetrahydro-psi,psi-carotene; LS-187678; LMPR01070256; 13587-06-9; CHEBI:27362;ζ-carotene | C40H60 | 540.9 g/mol | CC(=CCCC(=CCCC(=CC=CC(=CC=CC=C(C)C=CC=C(C)CCC=C(C)CCC=C(C)C)C)C)C)C |
| TCMBANKIN058901 | zeatin | (E)-2-methyl-4-(7H-purin-6-ylamino)but-2-en-1-ol; NCGC00142544-01; Zeatin; Z0876_SIGMA; Z1626_SIGMA; 2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol; CHEBI:16522; TNP00322; BRN 0616241; trans-Zeatin-8-14C; N6-(4-Hydroxy-3-methyl-2-buten-1-yl)adenine; Zeatine; trans-Zeatin hydrochloride; (E)-2-methyl-4-(purin-6-ylamino)-2-buten-1-ol; C00371; SMR000471895; 96088_FLUKA; 2-buten-1-ol, 2-methyl-4-(9H-purin-6-ylamino)-, (2E)-; ST057583; 1637-39-4; Z0164_SIGMA; Z2753_SIGMA; NCGC00017372-01; (E)-2-methyl-4-(1H-purin-6-ylamino)-2-buten-1-ol; 2-BUTEN-1-OL, 2-METHYL-4-(PURIN-6-YLAMINO)-, (E)-; MLS001074742; 2-Buten-1-ol, 2-methyl-4-(1H-purin-6-ylamino)-, (E)-; CHEBI:15333; (E)-Zeatin; 6-[4-hydroxy-3-methyl-but-2-enylamino]adenine; 2-methyl-4-(7H-purin-6-ylamino)but-2-en-1-ol; InChI=1/C10H13N5O/c1-7(4-16)2-3-11-9-8-10(13-5-12-8)15-6-14-9/h2,5-6,16H,3-4H2,1H3,(H2,11,12,13,14,15)/b7-2; (2E)-2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol; trans-Zeatin; ZINC04492895; ZINC01532631; N6-(4-Hydroxyisopentenyl)adenine; 6-(4-Hydroxy-3-methylbut-2-enylamino)purine; (E)-2-Methyl-4-(1H-purin-6-ylamino)but-2-en-1-ol; 2-methyl-4-(1H-purine-6-ylamino)-2-buten-1-ol; trans-zeatin | C10H13N5O | 219.24 g/mol | CC(=CCNC1=NC=NC2=C1NC=N2)CO |
| TCMBANKIN058915 | suberenon;suberenone | 7-Methoxy-6-(3-oxo-1-butenyl)coumarin; SUBERENONE; 7-Methoxy-6-(3-oxo-1-butenyl)-2H-1-benzopyran-2-one, 9CI; 7-methoxy-6-[(1E)-3-oxobut-1-en-1-yl]-2H-chromen-2-one; 7-methoxy-6-[(E)-3-oxobut-1-enyl]chromen-2-one; 7-methoxy-6-[-3-oxo-1-butenyl]-2h-1-benzopyran-2-one; 35897-95-1; AC1NT0MG | C14H12O4 | 244.24 g/mol | CC(=O)C=CC1=C(C=C2C(=C1)C=CC(=O)O2)OC |
| TCMBANKIN059662 | galanal a | C20H30O3 | 318.4 g/mol | CC1(CCCC2(C1CCC3(C2CC=C(CC3O)C=O)C=O)C)C | |
| TCMBANKIN059703 | Zeaxanthin | C40H56O2 | 568.87 | CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CC(CC2(C)C)O)C)C)C | |
| TCMBANKIN059709 | gamma-carotene | C40H56 | 536.9 g/mol | CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C)C)C | |
| TCMBANKIN059710 | cryptoxanthin | C40H56O | 552.87 | CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CC(CC2(C)C)O)C)C)C | |
| TCMBANKIN059711 | beta carotene | C40H56 | 536.87 | CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C | |
| TCMBANKIN059712 | cryptoxanthin epoxide | C40H56O2 | 568.87;568.96 | CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC23C(CC(CC2(O3)C)O)(C)C)C)C | |
| TCMBANKIN060000 | carotol | C15H26O | 222.37 | CC1=CCC2(CCC(C2(CC1)O)C(C)C)C | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060680 | stigmasterol-3-glucoside | C35H58O6 | 574.83 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN061576 | subaphylline | Subaphylline; (2E)-N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid; AX8235677; N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid; TC-158316; SFUVCMKSYKHYLD-FNORWQNLSA-N; KB-258187; 2-Propenamide, N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)- (9CI); AK104138; 501-13-3; MFCD01736565; NSC602818; 4-Oxy-3-methoxycinnamylputrescine; AKOS016006183; 2-Propenamide, N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)-; AC1NQZ3Q; (E)-N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide; CHEBI:9299; LS-53858; (2E)-N-(4-AMINOBUTYL)-3-(4-HYDROXY-3-METHOXYPHENYL)PROP-2-ENAMIDE; N-Feruloylputrescine; (E)-N-(4-aminobutyl)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enamide; (E)-N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide; Subaphyllin; N-(4-Aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide; Feruloylputrescine; ZINC1531868; MolPort-044-723-792; trans-N-Feruloylputrescine; 6850AB; C10497; 91000-11-2; AK677578; CINNAMAMIDE, N-(4-AMINOBUTYL)-4-HYDROXY-3-METHOXY-; AJ-26737; NSC-602818; (2E)-N-(4-Aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)-2-propenamide #; N-(E)-Feruloylputrescine; MolPort-023-333-229; N-(4-Aminobutyl)-4-hydroxy-3-methoxycinnamamide; subaphyllin | C14H20N2O3 | 264.32 g/mol | COC1=C(C=CC(=C1)C=CC(=O)NCCCCN)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab